Concepedia

Liesbet Tan

LT

Statistics

Publications

5

Citations

107

H-Index

5

Active since

2011

Affiliations

Health Sciences Authority(Current)

National University of Singapore

Duke-NUS Medical School

Liesbet Tan is an author at Health Sciences Authority specializing in pharmacogenetics, pharmacogenomics, and pharmacoepidemiology.

Publications per year

2011–2020

5

Publications

5

Hepatotoxic potential of asarones: in vitro evaluation of hepatotoxicity and quantitative determination in herbal products

Dhavalkumar Narendrabhai Patel, Han Kiat Ho, Liesbet Tan et al. · Frontiers in Pharmacology · 2015 · 28 citations · Full text

Pharmacy, Pharmacology, Toxicology +14

Usage Pattern of Carbamazepine and Associated Severe Cutaneous Adverse Reactions in Singapore Following Implementation of HLA-B*15:02 Genotyping as Standard-of-Care

Cynthia Sung, Liesbet Tan, Lie Michael George Limenta et al. · Frontiers in Pharmacology · 2020 · 26 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Is universal <i>HLA-B*15:02</i> screening a cost-effective option in an ethnically diverse population? A case study of Malaysia

Huey Yi Chong, Zahurin Mohamed, Liesbet Tan et al. · British Journal of Dermatology · 2017 · 23 citations · Full text

Life Sciences, Dermatology, Immunology +14

Tailoring of Recommendations to Reduce Serious Cutaneous Adverse Drug Reactions: A Pharmacogenomics Approach

Wei Chuen Tan‐Koi, Cynthia Sung, Yong Yeow Chong et al. · Pharmacogenomics · 2017 · 20 citations

Medicine, Dermatology, Pharmacology +17

Pharmacogenetic Risk for Adverse Reactions to Irinotecan in the Major Ethnic Populations of Singapore

Cynthia Sung, Pui Ling Lee, Liesbet Tan et al. · Drug Safety · 2011 · 10 citations

Medicine, Pharmacokinetics, Pharmacology +16

1–5 of 5